Management of respiratory symptoms in ALS. (Q37810000)

23 August 2017

Management of respiratory symptoms in ALS. (English)

1 reference

amyotrophic lateral sclerosis

23 August 2017

1 reference

1

1 reference

23 August 2017

17 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

258

1 reference

23 August 2017

3

1 reference

23 August 2017

359-365

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-010-5830-y

23 August 2017

0 references

cites work

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Causes of death in a post-mortem series of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Prognostic factors in ALS: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Regional cerebral blood flow during volitional expiration in man: a comparison with volitional inspiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Venous thrombosis in an ALS population over four years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Hypermetabolism in ALS patients: an early and persistent phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Spirometry in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Therapy development for ALS: lessons learned and path forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Respiratory apraxia in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Noninvasive ventilation in ALS: indications and effect on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

The effects of executive and behavioral dysfunction on the course of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

The course of the terminal phase in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Elective termination of respiratory therapy in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Medical and supportive care among people with ALS in the months before death or tracheostomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Imaging the brain during sniffing: A pilot fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

Is a four-hour use of non-invasive ventilation enough to define compliance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5830-Y

A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients

21 January 2018

1 reference

12 December 2020

Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis.

1 reference

12 December 2020

[Noninvasive intermittent self-ventilation as a palliative measure in amyotrophic lateral sclerosis]

1 reference

12 December 2020

Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: A six-month longitudinal study

1 reference

12 December 2020

Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey

1 reference

12 December 2020

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease

1 reference

12 December 2020

Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: Longitudinal study

1 reference

12 December 2020

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

1 reference

12 December 2020

10.1007/S00415-010-5830-Y

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21082322